Autoimmune heparin-induced thrombocytopenia

TE Warkentin - Journal of Clinical Medicine, 2023 - mdpi.com
Autoimmune thrombocytopenia (aHIT) is a severe subtype of heparin-induced
thrombocytopenia (HIT) with atypical clinical features caused by highly pathological IgG …

Immunologic effects of heparin associated with hemodialysis: Focus on heparin-induced thrombocytopenia

TE Warkentin - Seminars in Nephrology, 2023 - Elsevier
Intermittent hemodialysis (HD) is almost invariably performed with heparin, and thus HD
patients are at risk of developing the immune-mediated adverse effect heparin-induced …

Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure

L Schönborn, O Esteban, J Wesche, P Dobosz, M Broto… - Blood, 2023 - ashpublications.org
Platelet-activating anti-platelet factor 4 (PF4)/heparin antibodies and anti-PF4 antibodies
cause heparin-induced thrombocytopenia (HIT) and vaccine-induced immune …

Vaccine-induced immune thrombotic thrombocytopenia: what do we know hitherto?

R Roytenberg, A García-Sastre, W Li - Frontiers in medicine, 2023 - frontiersin.org
Vaccine-induced immune thrombotic thrombocytopenia (VITT), also known as thrombosis
with thrombocytopenia syndrome, is a catastrophic and life-threatening reaction to …

[HTML][HTML] 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19

S Schulman, DM Arnold, CA Bradbury… - Journal of thrombosis …, 2024 - Elsevier
Based on emerging evidence from the COVID-19 pandemic, the International Society on
Thrombosis and Haemostasis (ISTH) guidelines for antithrombotic treatment in COVID-19 …

Long-term outcomes after vaccine-induced thrombotic thrombocytopenia

V Panagiota, C Dobbelstein, S Werwitzke, A Ganser… - Viruses, 2022 - mdpi.com
Vaccine-induced thrombotic thrombocytopenia (VITT), or thrombosis with thrombocytopenia
syndrome (TTS), is a rare but serious complication of adenovirus-based vaccines against …

Outcomes after decompressive surgery for severe cerebral venous sinus thrombosis associated or not associated with vaccine-induced immune thrombosis with …

JO Pelz, M Kenda, A Alonso, N Etminan, M Wittstock… - Neurocritical Care, 2024 - Springer
Background Clinical observations indicated that vaccine-induced immune thrombosis with
thrombocytopenia (VITT)-associated cerebral venous sinus thrombosis (CVST) often has a …

Immunohistologic features of cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia

T Geeraerts, C Guilbeau-Frugier, C Garcia… - Neurology …, 2023 - AAN Enterprises
Objectives Vaccine-induced immune thrombotic thrombocytopenia (VITT), a recently
described entity characterized by thrombosis at unusual locations such as cerebral venous …

Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries

A van de Munckhof… - … journal of stroke, 2023 - journals.sagepub.com
Background: Adenovirus-based COVID-19 vaccines are extensively used in low-and middle-
income countries (LMICs). Remarkably, cases of cerebral venous sinus thrombosis due to …

Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia

J Weller, K Krzywicka… - European stroke …, 2024 - journals.sagepub.com
Introduction: There is little data on the role of endovascular treatment (EVT) of cerebral
venous sinus thrombosis (CVST) due to vaccine-induced immune thrombotic …